• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Toll样受体5(TLR5)和Toll样受体7(TLR7)在人乳头瘤病毒阳性和阴性舌底鳞状细胞癌中表达存在差异,且TLR7可能具有独立的预后影响。

TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence.

作者信息

Haeggblom Linnea, Näsman Anders, Ramqvist Torbjörn, Haglund Caj, Hagström Jaana, Mäkitie Antti, Dalianis Tina

机构信息

a Department of Oncology-Pathology , Karolinska Institute, CCK , Stockholm , Sweden.

b Department of Clinical Pathology, Cancer Center Karolinska , Karolinska Institute , Stockholm , Sweden.

出版信息

Acta Otolaryngol. 2019 Feb;139(2):206-210. doi: 10.1080/00016489.2018.1552014. Epub 2019 Feb 22.

DOI:10.1080/00016489.2018.1552014
PMID:30794027
Abstract

BACKGROUND

Human papillomavirus-positive (HPV) base of tongue squamous cell carcinoma (BOTSCC) has a better outcome than corresponding HPV cancer. TLR5 and TLR7 expression was previously shown to differ depending on HPV - status and correlate with outcome in oropharyngeal squamous cell carcinoma.

AIMS/OBJECTIVES: For validation, TLR5 and TLR7 were analyzed in a BOTSCC-cohort for correlation with HPV, survival, CD4 and CD8 tumor-infiltrating lymphocyte (TIL) counts, the latter being a well-documented prognostic marker.

MATERIALS AND METHODS

BOTSCC biopsies, (49HPV/28HPV) were analyzed by immunohistochemistry for TLR5 and TLR7, and correlated with the above parameters.

RESULTS

TLR5 expression was more frequently absent/weak than medium/strong in HPV compared to HPV BOTSCC (p < .001). The opposite was observed for TLR7 (p < .007). TLR5 and TLR7 expression did not correlate to survival in either the HPV or HPV cases, or to CD4 TILs. TLR5, (but not TLR7) expression was correlated to CD8 TIL counts (p = .023).

CONCLUSION AND SIGNIFICANCE

Absent/weak TLR5 and medium/strong TLR7 expression was validated as more frequent in HPV compared with HPV BOTSCC. A correlation between CD8 TIL counts, and TLR5 expression was disclosed, but not with TLR7. Therefore, it could be useful to investigate TLR7 further as a potential independent prognostic marker.

摘要

背景

人乳头瘤病毒阳性(HPV)的舌根鳞状细胞癌(BOTSCC)比相应的HPV阴性癌症预后更好。先前研究表明,Toll样受体5(TLR5)和Toll样受体7(TLR7)的表达因HPV状态而异,并且与口咽鳞状细胞癌的预后相关。

目的

为进行验证,在一个BOTSCC队列中分析TLR5和TLR7,以研究其与HPV、生存率、CD4和CD8肿瘤浸润淋巴细胞(TIL)计数的相关性,后者是一个有充分文献记载的预后标志物。

材料与方法

通过免疫组织化学分析49例HPV阳性/28例HPV阴性的BOTSCC活检标本中的TLR5和TLR7,并将其与上述参数进行相关性分析。

结果

与HPV阴性的BOTSCC相比,HPV阳性的BOTSCC中TLR5表达缺失/弱表达的情况比中等/强表达更为常见(p < 0.001)。TLR7的情况则相反(p < 0.007)。TLR5和TLR7的表达与HPV阳性或阴性病例的生存率均无相关性,与CD4 TILs也无相关性。TLR5(而非TLR7)的表达与CD8 TIL计数相关(p = 0.023)。

结论及意义

与HPV阴性的BOTSCC相比,HPV阳性的BOTSCC中TLR5表达缺失/弱表达及TLR7表达中等/强表达更为常见这一情况得到验证。研究发现CD8 TIL计数与TLR5表达相关,但与TLR7无关。因此,进一步研究TLR7作为潜在的独立预后标志物可能具有一定价值。

相似文献

1
TLR5 and TLR7 are differentially expressed in human papillomavirus-positive and negative base of tongue squamous cell carcinoma, and TLR7 may have an independent prognostic influence.Toll样受体5(TLR5)和Toll样受体7(TLR7)在人乳头瘤病毒阳性和阴性舌底鳞状细胞癌中表达存在差异,且TLR7可能具有独立的预后影响。
Acta Otolaryngol. 2019 Feb;139(2):206-210. doi: 10.1080/00016489.2018.1552014. Epub 2019 Feb 22.
2
Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.人乳头瘤病毒阳性扁桃体和舌根癌中FGFR3的过表达与预后相关。
Anticancer Res. 2018 Aug;38(8):4683-4690. doi: 10.21873/anticanres.12774.
3
CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.扁桃体和舌根鳞状细胞癌中与人类乳头状瘤病毒状态和临床结果相关的 CD8+ 和 CD4+ 肿瘤浸润淋巴细胞。
Eur J Cancer. 2013 Jul;49(11):2522-30. doi: 10.1016/j.ejca.2013.03.019. Epub 2013 Apr 6.
4
Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters.人乳头瘤病毒(HPV)16型E2、E5和E7 mRNA在HPV阳性扁桃体癌和舌根癌中的表达及其与临床结局和免疫参数的关系研究
Oral Oncol. 2015 Dec;51(12):1126-31. doi: 10.1016/j.oraloncology.2015.09.007. Epub 2015 Oct 5.
5
MicroRNA-155, -185 and -193b as biomarkers in human papillomavirus positive and negative tonsillar and base of tongue squamous cell carcinoma.微小 RNA-155、-185 和-193b 作为人乳头瘤病毒阳性和阴性扁桃体及舌根鳞状细胞癌的生物标志物。
Oral Oncol. 2018 Jul;82:8-16. doi: 10.1016/j.oraloncology.2018.04.021. Epub 2018 May 4.
6
Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.HPV 阴性口咽鳞状细胞癌患者体内 TLR5 表达升高,体外 TLR5 导致 NF-κΒ 激活缺失。
Exp Mol Pathol. 2020 Jun;114:104435. doi: 10.1016/j.yexmp.2020.104435. Epub 2020 Mar 30.
7
Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.非流行地区鼻咽癌中 Toll 样受体的表达。
BMC Cancer. 2019 Jun 25;19(1):624. doi: 10.1186/s12885-019-5816-9.
8
Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.扁桃体和舌根部癌症的蛋白表达及其与人类乳头状瘤病毒(HPV)和临床结果的关系。
Int J Mol Sci. 2018 Mar 25;19(4):978. doi: 10.3390/ijms19040978.
9
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.一种预测人乳头瘤病毒阳性扁桃体和舌根癌患者临床结局的模型。
Eur J Cancer. 2015 Aug;51(12):1580-7. doi: 10.1016/j.ejca.2015.04.024. Epub 2015 May 26.
10
Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.口咽鳞状细胞癌(OPSCC)患者的生存与 TNM8 相关——HPV 介导的非扁桃体、非舌根癌降期风险。
Eur J Cancer. 2020 Nov;139:192-200. doi: 10.1016/j.ejca.2020.08.003. Epub 2020 Sep 17.

引用本文的文献

1
Impact of and gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma.基因多态性对口腔鳞状细胞癌患者预后和生存的影响。
Biomol Biomed. 2024 Oct 17;24(6):1682-1691. doi: 10.17305/bb.2024.10550.
2
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives.靶向Toll样受体7/8进行免疫治疗:最新进展与展望
Biomark Res. 2022 Dec 7;10(1):89. doi: 10.1186/s40364-022-00436-7.
3
LncRNA GACAT1 induces tongue squamous cell carcinoma migration and proliferation via miR-149.长链非编码 RNA GACAT1 通过 miR-149 诱导舌鳞状细胞癌迁移和增殖。
J Cell Mol Med. 2021 Sep;25(17):8215-8221. doi: 10.1111/jcmm.16690. Epub 2021 Aug 10.
4
The Microenvironment of Tongue Cancer.舌癌的微环境。
Adv Exp Med Biol. 2020;1296:49-78. doi: 10.1007/978-3-030-59038-3_4.
5
The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.TLR 在头颈部鳞状细胞癌中的预后价值:系统评价和荟萃分析。
Int J Mol Sci. 2020 Sep 30;21(19):7255. doi: 10.3390/ijms21197255.
6
Impact of Genetic Variation in 3'UTR on NSCLC Genetic Susceptibility.3'非翻译区的基因变异对非小细胞肺癌遗传易感性的影响。
J Oncol. 2020 Apr 9;2020:7593143. doi: 10.1155/2020/7593143. eCollection 2020.